Open Access

miR‑342 inhibits glioma cell proliferation by targeting GPRC5A

  • Authors:
    • Jianjiao Wang
    • Yan Yang
    • Yuandong Cao
    • Xinyu Tang
  • View Affiliations

  • Published online on: May 15, 2019     https://doi.org/10.3892/mmr.2019.10242
  • Pages: 252-260
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Accumulating evidence suggests that microRNAs (miRNAs) play a key role in the biological behaviors and progression of glioma. However, the function and bio‑molecular mechanisms of miR‑342 in glioma remain largely unclear. In the present study, reverse transcription quantitative‑polymerase chain reaction and western blotting were performed to determine the mRNA and protein expression levels of the factors investigated. MTT assay was performed to examine the proliferation rates. Luciferase reporter assay was performed to test the binding between miRNA‑342 and its putative target. Data indicated that miR‑342 expression was markedly decreased in human glioma tissues and cell line U87, and reduced miR‑342 expression significantly promoted cell proliferation. In order to explore the mechanisms, G‑protein coupled receptor family C group 5 member A (GPRC5A) was identified as a target of miR‑342 and depletion of GPRC5A suppressed cell proliferation. Our findings demonstrated that miR‑342 regulates the cell proliferation of glioma by targeting GPRC5A, which indicates that miR‑342 is a target of interest regarding the treatment of refractory glioma, and it may provide a promising prognostic and therapeutic strategy for glioma treatment.

Related Articles

Journal Cover

July 2019
Volume 20 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, J., Yang, Y., Cao, Y., & Tang, X. (2019). miR‑342 inhibits glioma cell proliferation by targeting GPRC5A. Molecular Medicine Reports, 20, 252-260. https://doi.org/10.3892/mmr.2019.10242
MLA
Wang, J., Yang, Y., Cao, Y., Tang, X."miR‑342 inhibits glioma cell proliferation by targeting GPRC5A". Molecular Medicine Reports 20.1 (2019): 252-260.
Chicago
Wang, J., Yang, Y., Cao, Y., Tang, X."miR‑342 inhibits glioma cell proliferation by targeting GPRC5A". Molecular Medicine Reports 20, no. 1 (2019): 252-260. https://doi.org/10.3892/mmr.2019.10242